Nilesh J Samani Selected Research

Pathologic Constriction (Stenosis)

1/2021	Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia.
2/2012	Determinants and functional significance of myocardial perfusion reserve in severe aortic stenosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nilesh J Samani Research Topics

Disease

52	Heart Failure 01/2024 - 01/2010
48	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024 - 01/2003
29	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 06/2007
26	Myocardial Infarction 01/2022 - 03/2004
24	Hypertension (High Blood Pressure) 04/2024 - 09/2002
22	Coronary Disease (Coronary Heart Disease) 11/2020 - 01/2007
17	Inflammation (Inflammations) 09/2023 - 03/2004
17	Atherosclerosis 01/2020 - 10/2003
11	Stroke (Strokes) 10/2019 - 03/2004
10	Obesity 07/2019 - 01/2014
10	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2008
9	Atrial Fibrillation 09/2023 - 11/2005
6	Neoplasms (Cancer) 01/2023 - 04/2013
6	Atherosclerotic Plaque (Atheroma) 12/2022 - 01/2011
6	Thrombosis (Thrombus) 01/2022 - 11/2010
5	Vascular Diseases (Vascular Disease) 04/2022 - 08/2012
5	Diabetes Mellitus 11/2020 - 03/2010
5	Abdominal Aortic Aneurysm 05/2019 - 10/2007
4	Genetic Risk Score 04/2024 - 06/2015
4	Heart Diseases (Heart Disease) 12/2021 - 06/2015
4	COVID-19 08/2021 - 01/2020
4	Insulin Resistance 10/2014 - 11/2009
3	Acute Coronary Syndrome 03/2024 - 11/2013
3	Aortic Valve Stenosis (Aortic Stenosis) 03/2024 - 12/2016
3	Fibrosis (Cirrhosis) 09/2023 - 02/2012
3	Asthma (Bronchial Asthma) 11/2022 - 04/2014
3	Ischemic Stroke 01/2022 - 08/2012
3	Peripheral Arterial Disease 01/2022 - 08/2012
3	Necrosis 01/2022 - 01/2020
3	Venous Thromboembolism 01/2022 - 08/2012
3	Liver Diseases (Liver Disease) 04/2021 - 05/2015
3	Disease Progression 01/2020 - 07/2017
3	Cardiomyopathies (Cardiomyopathy) 01/2020 - 12/2014
3	Glioma (Gliomas) 05/2017 - 07/2014
3	Hypoxia (Hypoxemia) 11/2015 - 08/2008
3	Gout 02/2013 - 10/2008
2	Mitral Valve Insufficiency (Mitral Regurgitation) 12/2023 - 08/2022
2	Adenocarcinoma of Lung 01/2023 - 05/2017
2	Spontaneous Coronary Artery Dissection 04/2021 - 01/2021
2	Pathologic Constriction (Stenosis) 01/2021 - 02/2012
2	Renal Insufficiency (Renal Failure) 11/2020 - 07/2017
2	Rupture 11/2020 - 01/2003
2	Iron Deficiencies 08/2020 - 01/2019
2	Infarction (Infarctions) 01/2020 - 12/2018
2	Hypertrophy 01/2020 - 02/2012

Drug/Important Bio-Agent (IBA)

32	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2008
25	LipidsIBA 07/2023 - 01/2008
23	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2004
12	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2023 - 01/2010
10	CholesterolIBA 12/2022 - 11/2008
10	LDL CholesterolIBA 12/2021 - 08/2008
8	EnzymesIBA 07/2021 - 05/2010
8	HDL CholesterolIBA 01/2018 - 08/2010
8	Triglycerides (Triacylglycerol)IBA 01/2017 - 05/2010
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2007
7	oxidized low density lipoproteinIBA 10/2020 - 09/2009
6	pro-brain natriuretic peptide (1-76)IBA 09/2023 - 03/2020
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2018
5	CytokinesIBA 09/2023 - 01/2010
5	RNA (Ribonucleic Acid)IBA 01/2023 - 04/2015
5	P-2 (P 2)IBA 12/2022 - 01/2009
5	C-Reactive ProteinIBA 01/2016 - 10/2008
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2022 - 12/2013
4	Lipoprotein(a)IBA 01/2022 - 08/2012
4	MicroRNAs (MicroRNA)IBA 04/2021 - 04/2015
4	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 08/2010
4	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2018
4	Insulin (Novolin)FDA Link 01/2019 - 01/2012
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2007
4	HDL LipoproteinsIBA 01/2018 - 01/2016
4	Glucose (Dextrose)FDA LinkGeneric 06/2016 - 01/2012
4	telomerase RNA (bTR)IBA 01/2016 - 04/2013
4	Uric Acid (Urate)IBA 02/2013 - 01/2008
3	ProteomeIBA 03/2024 - 01/2020
3	SeleniumIBA 01/2024 - 01/2020
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2023 - 07/2014
3	LDL Receptors (LDL Receptor)IBA 12/2022 - 08/2008
3	Endothelial Protein C ReceptorIBA 04/2022 - 07/2017
3	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022 - 01/2019
3	CreatinineIBA 01/2021 - 07/2013
3	Mineralocorticoid Receptor AntagonistsIBA 01/2021 - 10/2017
3	Angiotensin-Converting Enzyme 2IBA 12/2020 - 01/2020
3	HomocysteineIBA 12/2019 - 02/2012
3	SodiumIBA 10/2017 - 10/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 10/2014
3	MorpholinosIBA 11/2015 - 11/2010
3	AdiponectinIBA 09/2014 - 12/2009
3	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 08/2008 - 03/2004
2	AdrenomedullinIBA 01/2023 - 01/2019
2	ApolipoproteinsIBA 12/2022 - 01/2019
2	LigandsIBA 01/2022 - 11/2009
2	Growth Differentiation Factor 15IBA 08/2021 - 03/2020
2	amidoximeIBA 04/2021 - 01/2020
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2021 - 08/2020
2	Interleukin-6 (Interleukin 6)IBA 11/2020 - 01/2019
2	Phytosterols (Plant Sterols)IBA 10/2020 - 08/2010
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2020 - 08/2006
2	GadoliniumIBA 01/2020 - 02/2012

Therapy/Procedure

17	Therapeutics 03/2024 - 02/2011
3	Percutaneous Coronary Intervention 01/2022 - 12/2018